AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
CEFTRIAXONE SODIUM USP
9 registrations across 5 African markets— 6 active
Markets with CEFTRIAXONE SODIUM USP
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Scotxone-1g DRY POWDER OF INJECTION | 🇷🇼Rwanda | Covalent Laboratories Private Limited | active | May 2031 |
| Ceftrisone 1000 Powder And Solution For Solution For Injectio | 🇰🇪Kenya | Unosource Pharma Limited | active | Apr 2031 |
| INNO-CEPT 250mg INJECTION (Each vial contains Ceftriaxone Sodium USP 250mg) | 🇬🇭Ghana | — | active | Jan 2031 |
| INNO-CEPT 250mg INJECTION (Each vial contains Ceftriaxone Sodium USP 250mg) | 🇬🇭Ghana | — | active | Jan 2031 |
| SANAXONE Powder for injection | 🇷🇼Rwanda | M/S SANSE LABORATORIES PVT LTD | active | Aug 2029 |
| GLAXONE 1G Injection | 🇰🇪Kenya | GLAXONE 1G | active | Jan 2027 |
| UTRIXONE-1000 1000MG INJECTION INJECTION | 🇲🇼Malawi | — | expired | Mar 2025 |
| BGCEF INJECTION INJECTION1 VIAL + 2 DILUENT AMPOULES | 🇳🇬Nigeria | BG PHARMA & HEALTHCARE LTD PLOT 859 GUDU DISTRICT | expired | Oct 2021 |
| MONOCEF 1G INJECTION INJECTION | 🇲🇼Malawi | — | expired | Jun 2015 |
CEFTRIAXONE SODIUM USP in Africa — Regulatory Overview
CEFTRIAXONE SODIUM USP is registered across 5 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Kenya, Malawi, Rwanda and 1 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 9 registrations, 6 (67%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.